The American Telemedicine Association announced that the U.S. Drug Enforcement Administration, or DEA, granted a 1-year extension for remote prescribing of controlled medications just before the ...
The extension, released shortly before the flexibilities were set to expire at the end of 2025, gives regulators more time to ...
The Drug Enforcement Administration (DEA) published a yearlong extension of telemedicine prescribing flexibilities for controlled substances Tuesday, just one day before the end of the year, when the ...
The extension allows providers to continue remotely prescribing Schedule II–V controlled substances under specific conditions to prevent a disruptive "telemedicine cliff." ...
In the letter, the telehealth advocates pushed the DEA to work directly with experts and other stakeholders on how to craft policy on virtual prescribing — an increasingly urgent concern given the ...
The Drug Enforcement Administration (DEA) just released a new regulation temporarily extending the COVID-era flexibilities for prescribing controlled substances via telemedicine. This third extension ...
For elements 7 and 8 above, the NPRM describes how the DEA may adopt one or both proposals. The appointment of a lead for the DEA by President-elect Donald Trump remains pending, leaving uncertainty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback